We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 of the French drugmaker’s patents, in particular its disposable insulin glargine pre-filled pen Lantus as well as vial-drug diabetes products.